These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 16394334)
1. MRI of perfluorocarbon emulsion kinetics in rodent mammary tumours. Fan X; River JN; Muresan AS; Popescu C; Zamora M; Culp RM; Karczmar GS Phys Med Biol; 2006 Jan; 51(2):211-20. PubMed ID: 16394334 [TBL] [Abstract][Full Text] [Related]
2. Investigation of vaporized submicron perfluorocarbon droplets as an ultrasound contrast agent. Reznik N; Williams R; Burns PN Ultrasound Med Biol; 2011 Aug; 37(8):1271-9. PubMed ID: 21723449 [TBL] [Abstract][Full Text] [Related]
3. Two-compartment radial diffusive exchange analysis of the NMR lineshape of (129)Xe dissolved in a perfluorooctyl bromide emulsion. Gherase MR; Wallace JC; Cross AR; Santyr GE J Chem Phys; 2006 Jul; 125(4):44906. PubMed ID: 16942191 [TBL] [Abstract][Full Text] [Related]
4. Silica-coated quantum dots for optical evaluation of perfluorocarbon droplet interactions with cells. Gorelikov I; Martin AL; Seo M; Matsuura N Langmuir; 2011 Dec; 27(24):15024-33. PubMed ID: 22026433 [TBL] [Abstract][Full Text] [Related]
5. Peripheral washout phenomenon in an animal tumour model: comparison of dynamic magnetic resonance imaging using a small molecular contrast medium with histology. Drees R; Hünigen H; Wagner S; Schnorr J; Plendl J; Taupitz M Vet Comp Oncol; 2008 Sep; 6(3):151-61. PubMed ID: 19178675 [TBL] [Abstract][Full Text] [Related]
6. Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection. Janjic JM; Srinivas M; Kadayakkara DK; Ahrens ET J Am Chem Soc; 2008 Mar; 130(9):2832-41. PubMed ID: 18266363 [TBL] [Abstract][Full Text] [Related]
7. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging. Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699 [TBL] [Abstract][Full Text] [Related]
8. MRI detection of tumor in mouse lung using partial liquid ventilation with a perfluorocarbon-in-water emulsion. Huang MQ; Basse PH; Yang Q; Horner JA; Hichens TK; Ho C Magn Reson Imaging; 2004 Jun; 22(5):645-52. PubMed ID: 15172058 [TBL] [Abstract][Full Text] [Related]
10. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates. Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033 [TBL] [Abstract][Full Text] [Related]
11. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model. Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099 [TBL] [Abstract][Full Text] [Related]
12. Effects of a new perfluorocarbon emulsion on human plasma and whole-blood viscosity in the presence of albumin, hydroxyethyl starch, or modified fluid gelatin: an in vitro rheologic approach. Jouan-Hureaux V; Audonnet-Blaise S; Lacatusu D; Krafft MP; Dewachter P; Cauchois G; Stoltz JF; Longrois D; Menu P Transfusion; 2006 Nov; 46(11):1892-8. PubMed ID: 17076843 [TBL] [Abstract][Full Text] [Related]
13. Perfluorocarbon distribution to liver, lung and spleen of emulsions of perfluorotributylamine (FTBA) in pigs and rats and perfluorooctyl bromide (PFOB) in rats and dogs by 19F NMR spectroscopy. McGoron AJ; Pratt R; Zhang J; Shiferaw Y; Thomas S; Millard R Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1243-50. PubMed ID: 7849929 [TBL] [Abstract][Full Text] [Related]
14. Amir N; Green D; Kent J; Xiang Y; Gorelikov I; Seo M; Blacker M; Janzen N; Czorny S; Valliant JF; Matsuura N Nucl Med Biol; 2017 Nov; 54():27-33. PubMed ID: 28863330 [TBL] [Abstract][Full Text] [Related]
15. 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. Lanza GM; Winter PM; Neubauer AM; Caruthers SD; Hockett FD; Wickline SA Curr Top Dev Biol; 2005; 70():57-76. PubMed ID: 16338337 [TBL] [Abstract][Full Text] [Related]
16. Vaporization dynamics of volatile perfluorocarbon droplets: a theoretical model and in vitro validation. Doinikov AA; Sheeran PS; Bouakaz A; Dayton PA Med Phys; 2014 Oct; 41(10):102901. PubMed ID: 25281982 [TBL] [Abstract][Full Text] [Related]
17. Perfluorocarbon in microcirculation during ischemia reperfusion. Cabrales P; Tsai AG; Intaglietta M J Am Coll Surg; 2007 Feb; 204(2):225-35. PubMed ID: 17254926 [TBL] [Abstract][Full Text] [Related]
18. Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents. Neubauer AM; Caruthers SD; Hockett FD; Cyrus T; Robertson JD; Allen JS; Williams TD; Fuhrhop RW; Lanza GM; Wickline SA J Cardiovasc Magn Reson; 2007; 9(3):565-73. PubMed ID: 17365236 [TBL] [Abstract][Full Text] [Related]
19. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography. de Haën C; Anelli PL; Lorusso V; Morisetti A; Maggioni F; Zheng J; Uggeri F; Cavagna FM Invest Radiol; 2006 Mar; 41(3):279-91. PubMed ID: 16481911 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI. Hirschberg H; Wu GN; Madsen SJ Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]